Liquid Blenz Good Brain Tonic Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
LIQUID BLENZ CORP is recalling Liquid Blenz Good Brain Tonic due to potential under-processing that may allow growth of Clostridium botulinum.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 11, 2026 and geographically references New York. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Food.
What Happened
LIQUID BLENZ CORP has initiated a voluntary recall of Liquid Blenz Good Brain Tonic because the product may be under-processed, resulting in potential growth of Clostridium botulinum, and lists health claims.
Which Products Are Affected
The recall covers Liquid Blenz Good Brain Tonic in 16 oz (UPC: 860010984468) and 32 oz (UPC: 860010984475) sizes. A total of 18,190 bottles are affected. The products were distributed in NY and through online sales.
What You Should Do
Consumers should not use the recalled products. Contact LIQUID BLENZ CORP for return or refund information using the details provided in the firm's notification.
Why This Matters
The recall addresses a potential risk of Clostridium botulinum growth in the affected tonic distributed in New York and online.
Source
FDA recall number H-0794-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (848 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.